Latest research into retatritide peptide demonstrate significant potential for treating excess body and non-insulin dependent diabetes mellitus. The peptide, a dual agonist of glucagon-like peptide-1 and GIP, seems to provide greater weight loss and glycemic control compared existing medications. Ongoing research efforts are necessary to thoroug… Read More